Based on the above progress, we recently examined the effects of PI3K and FGFR inhibitors in childhood neuroblastoma (NB) and MB cell lines (with/without PI3K mutations) in vitro and demonstrated that these inhibitors and especially in combination efficiently decreased viability as well as inhibition in the increase in cell confluence of the cell lines (28–30). Here, PIK3CA is linked to neuroblastoma.